Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. Pescarmona
RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Related publications
Doxorubicin Resistance Induces IL6 Activation in the Colon Cancer Cell Line LS180
Oncology Letters
Cancer Research
Oncology
Dragon (RGMb) Induces Oxaliplatin Resistance in Colon Cancer Cells
Oncotarget
Oncology
Annexin A1 Is Involved in Resistance to 5-Fu in Colon Cancer Cells
Oncology Reports
Medicine
Cancer Research
Oncology
miR-27b-3p Is Involved in Doxorubicin Resistance of Human Anaplastic Thyroid Cancer Cells via Targeting PPARγ
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Doxorubicin Resistance in Breast Cancer Cells Is Mediated by Extracellular Matrix Proteins
BMC Cancer
Cancer Research
Oncology
Genetics
Combination of Chemotherapy and Au-Nanoparticle Photothermy in the Visible Light to Tackle Doxorubicin Resistance in Cancer Cells
Scientific Reports
Multidisciplinary
Enhancement of Doxorubicin Cytotoxicity by Verapamil in Human Breast Cancer Cells
Journal of Pharmaceutical Research International
MicroRNA-522 Reverses Drug Resistance of Doxorubicin-Induced HT29 Colon Cancer Cell by Targeting ABCB5
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression
PLoS ONE
Multidisciplinary